Redmile Group LLC insider trades
Open-market stock purchases and sales by Redmile Group LLC, 10% Owner at Attovia Therapeutics, Inc, from SEC Form 4 filings since Aug 6, 2015.
Track record: 5% of 86 scored buys are up 5% or more since purchase, averaging -49%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 6, 2026 | ATTO Attovia Therapeutics, Inc | Bought (not open market) | — |
| Aug 6, 2026 | ATTO Attovia Therapeutics, Inc | Bought | $3.4M |
| Aug 6, 2026 | ATTO Attovia Therapeutics, Inc | Bought | $6.8M |
| Aug 6, 2026 | ATTO Attovia Therapeutics, Inc | Bought (not open market) | — |
| Jul 22, 2026 | ATRA Atara Biotherapeutics, Inc | Bought (not open market) | — |
| Jul 22, 2026 | ATRA Atara Biotherapeutics, Inc | Sold (not open market) | — |
| Jul 22, 2026 | ATRA Atara Biotherapeutics, Inc | Bought (not open market) | — |
| Jul 22, 2026 | ATRA Atara Biotherapeutics, Inc | Bought (not open market) | — |
| Jul 22, 2026 | ATRA Atara Biotherapeutics, Inc | Bought (not open market) | — |
| Jun 12, 2026 | FATE Fate Therapeutics Inc | Bought (not open market) | — |
| Apr 20, 2026 | FATE Fate Therapeutics Inc | Bought (not open market) | — |
| Apr 20, 2026 | FATE Fate Therapeutics Inc | Bought (not open market) | — |
| Apr 20, 2026 | FATE Fate Therapeutics Inc | Bought (not open market) | — |
| Apr 20, 2026 | FATE Fate Therapeutics Inc | Bought (not open market) | — |
| Apr 20, 2026 | FATE Fate Therapeutics Inc | Bought (not open market) | — |
| Apr 2, 2026 | ADCT ADC Therapeutics SA | Sold | $8.6M |
| Apr 2, 2026 | ADCT ADC Therapeutics SA | Sold | $8.3M |
| Apr 1, 2026 | ADCT ADC Therapeutics SA | Sold | $643K |
| Apr 1, 2026 | ADCT ADC Therapeutics SA | Sold | $617K |
| Mar 31, 2026 | ADCT ADC Therapeutics SA | Sold | $736K |
| Mar 31, 2026 | ADCT ADC Therapeutics SA | Sold | $707K |
| Oct 27, 2025 | ADCT ADC Therapeutics SA | Bought | $15M |
Companies traded
- ATTO Attovia Therapeutics, Inc: 2 buys, last Aug 6, 2026
- ATRA Atara Biotherapeutics, Inc: other filings, last Jul 22, 2026
- FATE Fate Therapeutics Inc: 10 buys, 2 sales, last Jun 12, 2026
- ADCT ADC Therapeutics SA: 27 buys, 7 sales, last Apr 2, 2026
- STTK Shattuck Labs, Inc: 7 buys, 1 sale, last Aug 25, 2025
- IGMS IGM Biosciences, Inc: 11 buys, 1 sale, last Aug 14, 2025
- AUGX Augmedix, Inc: 4 buys, last Oct 2, 2024
- ABSI Absci Corp: 2 buys, last Jun 12, 2024
- SNCE Science 37 Holdings, Inc: other filings, last Mar 12, 2024
- RYZB RayzeBio, Inc: other filings, last Sep 19, 2023
- MDVL MedAvail Holdings, Inc: other filings, last Jun 16, 2023
- ZYME Zymeworks Inc: 1 buy, last Oct 13, 2022